# Light & Wonder, Inc.: overview

LAWIL · OTC · CIK 750004 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lawil.md) · [Financials](/companies/lawil/financials.md) · [Filings](/companies/lawil/filings.md) · [Insiders](/companies/lawil/insiders.md)

Latest reported revenue: [$828.0m](/filings/0000750004-26-000033.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000750004-26-000033).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [817](/filings/0000750004-25-000072.md) | [797 d](/filings/0000750004-26-000012.md) | [774](/filings/0000750004-26-000022.md) | [809](/filings/0000750004-26-000033.md) | [841](/filings/0000750004-25-000072.md) | [890 d](/filings/0000750004-26-000012.md) | [790](/filings/0000750004-26-000022.md) | [828](/filings/0000750004-26-000033.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [19.5%](/filings/0000750004-25-000072.md) | [21.1% d](/filings/0000750004-26-000012.md) | [22.0%](/filings/0000750004-26-000022.md) | [25.0%](/filings/0000750004-26-000033.md) | [27.2%](/filings/0000750004-25-000072.md) | [9.3% d](/filings/0000750004-26-000012.md) | [16.5%](/filings/0000750004-26-000022.md) | [26.9%](/filings/0000750004-26-000033.md) |
| Net margin | % | [7.8%](/filings/0000750004-24-000064.md) | [13.6% d](/filings/0000750004-26-000012.md) | [10.6%](/filings/0000750004-26-000033.md) | [11.7%](/filings/0000750004-26-000033.md) | [13.6%](/filings/0000750004-25-000072.md) | [(1.7%) d](/filings/0000750004-26-000012.md) | [6.6%](/filings/0000750004-26-000033.md) | [14.5%](/filings/0000750004-26-000033.md) |
| Diluted EPS | $ per share | [0.71](/filings/0000750004-25-000072.md) | not reported | [0.94](/filings/0000750004-26-000022.md) | [1.11](/filings/0000750004-26-000033.md) | [1.34](/filings/0000750004-25-000072.md) | not reported | [0.66](/filings/0000750004-26-000022.md) | [1.53](/filings/0000750004-26-000033.md) |
| Free cash flow | $m | not reported | not reported | [124](/filings/0000750004-26-000022.md) | [28.0 d](/filings/0000750004-26-000033.md) | not reported | not reported | [65.0](/filings/0000750004-26-000022.md) | [158 d](/filings/0000750004-26-000033.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Net income: us-gaap:ProfitLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,153](/filings/0000750004-24-000015.md) | [2,512](/filings/0000750004-25-000016.md) | [2,902](/filings/0000750004-26-000012.md) | [3,188](/filings/0000750004-26-000012.md) | [3,314](/filings/0000750004-26-000012.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [5.1%](/filings/0000750004-24-000015.md) | [10.9%](/filings/0000750004-25-000016.md) | [17.8%](/filings/0000750004-26-000012.md) | [21.0%](/filings/0000750004-26-000012.md) | [20.6%](/filings/0000750004-26-000012.md) |
| Net margin | % | [17.2%](/filings/0000750004-24-000015.md) | [146.3%](/filings/0000750004-25-000016.md) | [5.6%](/filings/0000750004-26-000012.md) | [10.5%](/filings/0000750004-26-000012.md) | [8.3%](/filings/0000750004-26-000012.md) |
| Diluted EPS | $ per share | [3.77](/filings/0000750004-24-000015.md) | [38.78](/filings/0000750004-25-000016.md) | [1.75](/filings/0000750004-26-000012.md) | [3.68](/filings/0000750004-26-000012.md) | [3.26](/filings/0000750004-26-000012.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/lawil/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [GAMMA Investing LLC](/funds/2010235.md) | 2026-06-30 | $36.8k | 475 |  | Reduced −163 |
| [HUNTINGTON NATIONAL BANK](/funds/49205.md) | 2026-06-30 | $23.3k | 301 |  | Unchanged |
| [Front Row Advisors LLC](/funds/1729254.md) | 2026-06-30 | $11.4k | 125 |  | Unchanged |
| [HANTZ FINANCIAL SERVICES, INC.](/funds/1071061.md) | 2026-06-30 | $39 | 507 |  | Reduced −216 |

## Recent filings

[All 1,922 filings](/companies/lawil/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-17 | 21:27 ET | [8-K](/filings/0001104659-26-097948.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-097948 |
| 2026-08-04 | 21:16 ET | [10-Q](/filings/0000750004-26-000033.md) | Quarterly report, period 2026-06-30 | 0000750004-26-000033 |
| 2026-08-04 | 21:04 ET | [8-K](/filings/0000750004-26-000032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000750004-26-000032 |
| 2026-07-13 | 21:15 ET | [8-K](/filings/0001104659-26-083154.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-083154 |
| 2026-06-15 | 11:55 ET | [8-K](/filings/0001104659-26-073783.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-073783 |
| 2026-06-11 | 21:15 ET | [8-K](/filings/0001104659-26-073012.md) | 5.07 Shareholder vote results | 0001104659-26-073012 |
| 2026-06-10 | 21:15 ET | [8-K](/filings/0001104659-26-072422.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-072422 |
| 2026-05-06 | 21:04 ET | [10-Q](/filings/0000750004-26-000022.md) | Quarterly report, period 2026-03-31 | 0000750004-26-000022 |
| 2026-05-06 | 20:54 ET | [8-K](/filings/0000750004-26-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000750004-26-000021 |
| 2026-04-30 | 20:49 ET | [DEF 14A](/filings/0001104659-26-053082.md) | Proxy statement, period 2026-06-10 | 0001104659-26-053082 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000750004-26-000012.md), filed Feb 24, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/ecbf0e5d-a363-4852-80b5-509d44e2189b)

## About the filer

- CIK: 750004
- Tickers: LAWIL, LNWO
- Exchange: OTC
- SIC code: 7373 Services-Computer Integrated Systems Design
- State of incorporation: NV
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.